IRulya Therapeutics: Trust traded 3,471 shares

The notice lists an aggregate market value of $103,534 and identifies former board member David Lamond as Blue Devil Trust’s trustee.

Available on EDGAR 11/05/2026 - 03:43 PM EST Accepted by SEC EDGAR 11/05/2026 - 03:42 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

IRulya Therapeutics, Inc. (IRLA) received a Form 144 notice reporting an executed trade in 3,471 common shares by Blue Devil Trust on October 9, 2026, with a listed aggregate market value of $103,534. Former Board Member David Lamond is identified as the trust’s trustee. The remarks say the trade was executed under QNCX, which began trading as IRLA following a name change on October 10, 2026.

Key Figures

Shares in reported trade: 3,471 common shares Aggregate market value: $103,534 Issuer shares outstanding: 1,017,063 shares

3 metrics

Shares in reported trade 3,471 common shares Trade dated October 9, 2026

Aggregate market value $103,534 Reported trade

Issuer shares outstanding 1,017,063 shares Figure listed in securities information

Key Terms

Rule 144, aggregate market value, shares outstanding

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

aggregate market value financial

"Aggregate market value"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

shares outstanding financial

"Number of shares outstanding"

Shares outstanding are the total number of a company’s stock units held by all shareholders, including institutional investors and company insiders — think of them as the total number of slices of the company’s ownership pie. Investors use this number to calculate how much of the company each share represents, and it directly affects per-share measures like earnings per share, ownership percentage and valuation; when the slice count changes, an investor’s claim and the company’s per-share metrics change too.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many IRLA shares did Blue Devil Trust sell?

Blue Devil Trust’s reported trade involved 3,471 common shares on October 9, 2026, with a listed aggregate market value of $103,534.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001770790
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	IRulya Therapeutics, Inc.
SEC File Number	001-38890
Address of Issuer	101 College Street Suite210 New Haven CONNECTICUT 06510
Phone	718-921-8124
Name of Person for Whose Account the Securities are To Be Sold	Blue Devil Trust
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Former Board Member

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 2 Pickwick Plz FL 4 Greenwich CT 06830	3471	103534	1017063	10/09/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	05/15/2020	Open Market	Quince Therapeautic Inc. now IRulya			27	05/15/2020	cash
Common	05/19/2020	Open Market	Quince Therapeautic Inc. now IRulya			196	05/19/2020	Cash
Common	06/04/2020	Open Market	Quince Therapeautic Inc. now IRulya			246	06/04/2020	Cash
Common	08/31/2023	open market	Quince Therapeautic Inc. now IRulya			410	08/31/2023	cash
Common	03/04/2021	Open Market	Quince Therapeautic Inc. now IRulya			500	03/04/2021	Cash
Common	08/17/2023	Open Market	Quince Therapeautic Inc. now IRulya			1250	08/17/2023	cash
Common	12/01/2023	open market	Quince Therapeautic Inc. now IRulya			216	12/01/2023	cash
Common	12/07/2023	open market	Quince Therapeautic Inc. now IRulya			287	12/07/2023	cash
Common	12/14/2023	open market	Quince Therapeautic Inc. now IRulya			339	12/14/2023	cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Form being filed for trade executed 10/9/2026 under QNCX which now trades as IRLA due to name change 10/10/26, Former Board Member David Lamond is the trustee of Blue Devil Trust, the seller
Date of Notice	11/05/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	David Lamond
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)